Smoking raises risk of midlife memory loss, confusion: Study
Columbus, December 22: Middle-aged smokers are significantly more likely than nonsmokers to experience memory loss and confusion, and those who recently quit are less likely to experience cognitive decline, according to a new study.
Also Read: Centre steps up surveillance amid global Covid surge
The association we saw was most significant in the 45-59 age group, suggesting that quitting at that stage of life may have a benefit for cognitive health," Wing said. A similar difference wasn't found in the oldest group in the study, which could mean that quitting earlier affords people greater benefits, he said.
Data for the study came from the national 2019 Behavioral Risk Factor
Surveillance System Survey and allowed the research team to compare subjective cognitive decline
(SCD) measures for current smokers, recent former smokers, and those who had
quit years earlier. The analysis included 136,018 people 45 and older, and
about 11% reported SCD.
The prevalence of SCD among smokers in the study was almost 1.9 times that of
nonsmokers. The prevalence among those who had quit less than 10 years ago was
1.5 times that of nonsmokers. Those who quit more than a decade before the
survey had an SCD prevalence just slightly above the nonsmoking group.
"These findings could imply that the time since smoking cessation does
matter, and may be linked to cognitive outcomes," Rajczyk said.
The simplicity of SCD, a relatively new measure, could lend itself to wider
applications, she said.
"This is a simple assessment that could be easily done routinely, and at
younger ages than we typically start to see cognitive declines that rise to the
level of a diagnosis of Alzheimer's Disease or dementia," Rajczyk said,
adding, "It's not an intensive battery of questions. It's more a personal
reflection of your cognitive status to determine if you're feeling like you're
not as sharp as you once were."
Many people don't have access to more in-depth screenings, or to specialists --
making potential applications for measuring SCD even greater, she said.
Wing said it's important to note that these self-reported experiences don't
amount to a diagnosis, nor do they confirm independently that a person is
experiencing decline out of the normal aging process. But, he said, they could
be a low-cost, simple tool to consider employing more broadly.
Amy Ferketich, a professor of epidemiology at Ohio State, also worked on the
study.
Also Read: 'Ukraine is alive and kicking': Zelenskyy to US Congress
- ANI
